Main Menu

Acceleron Pharma Inc.

(NASDAQ GM: XLRN)

Rigrodsky Law, P.A. is investigating Acceleron Pharma Inc. (“Acceleron”) regarding possible breaches of fiduciary duties and other violations of law related to Acceleron’s agreement to be acquired by Merck & Co. Under the terms of the agreement, Acceleron’s shareholders will receive $180 in cash for each share of Acceleron common stock they own.

Join This Action

Alternatively, you may upload your transactions using the upload button below or email them to info@rl-legal.com.

Draw your signature below using your mouse* [Clear]

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

Date of signing: 10/22/2021


* Indicates a required field.

Back to Page